A new research project has been awarded over £6m to develop a toolkit to allow 3D printed medicines to be manufactured effectively bringing innovations like biological personalised pills and ‘living plasters’ closer to commercial production. The EPSRC funded five-year project is a collaboration being led by researchers from Engineering, Life Sciences and Pharmacy at the University of Nottingham, alongside the Universities of Cambridge, Reading and Strathclyde with international partners at Lawrence Livermore National Laboratory, ETH, CSIRO and a range of industrial partners including AstraZeneca and Pfizer. The teams will work together to develop a toolkit that will allow industry to identify, select and process the correct materials to 3D print into new regenerative medicines and pharmaceuticals.
Professor Clive Roberts, who is leading the ‘Biopill’ work package of the new research project, says: “Whilst the three products we are developing are in their infancy we are hoping to be able to develop these innovations to demonstrate the capabilities of the 3D printing tool kit and be able to show how we can combine materials to provide personalised medicines and implants that are safe, effective and low cost.”
Full article can be accessed here.
University of NottinghamMedical School
Queen's Medical CentreNottingham NG7 2UH
Connect with the University of Nottingham through social media and our blogs.
Campus maps | More contact information | Jobs